ID | 115863 |
著者 | |
キーワード | American Diabetes Association (ADA)
Dual Action of Liraglutide and Insulin Degludec (DUAL) studies
Xultophy
Multiple Daily Injection (MDI)
Once Daily Injection
|
資料タイプ |
学術雑誌論文
|
抄録 | American Diabetes Association (ADA) has announced the new version of the standards of Medical Care in Diabetes-2021. The guideline of the diabetic patients with Older Adults seems to be used for a wide range of clinical practice. Among them, several impressive comments were found, where “Once-daily basal insulin injection therapy is associated with minimal side effects and maybe a reasonable option in many elder patients”. Recent topic includes Dual Action of Liraglutide and insulin degludec (DUAL) studies, and Xultophy has shown beneficial efficacy. Consequently, the trend would be developed from multiple daily injection (MDI) method to once daily injection.
|
掲載誌名 |
Diabetes Research : Open Access
|
出版者 | Asploro
|
巻 | 3
|
号 | 1
|
開始ページ | 11
|
終了ページ | 15
|
発行日 | 2021-02-17
|
権利情報 | This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
医学系
|